Skip to main content
SpringerLink
Log in

Treatment of MASLD

  • Chapter
  • First Online:
Managing Complex Cases in Gastroenterology

  • 90 Accesses

Abstract

A researcher specializing in MASLD discusses a patient’s management. The strategies of weight loss, diet, exercise, and drinking coffee are discussed. Use of FibroScan is reviewed. Three different scenarios based on liver biopsy are discussed. Steatosis without steatohepatitis, steatohepatitis without fibrosis, and steatohepatitis with stage 3 fibrosis. Prognosis in each setting, reversibility, and management are all discussed. Screening and surveillance strategies are reviewed. Pharmacologic therapies currently available, and others in the future are discussed. The use of bariatric surgery is also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rinella ME, Lazarus JV, Ratziu V, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;29(1):101133. https://doi.org/10.1097/HEP.0000000000000520.

    Article  Google Scholar 

  2. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67:328–57.

    Article  PubMed  Google Scholar 

  3. Sourianarayanane A, Pagadala MR, Kirwan JP. Management of non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol. 2013;59(1):69–87.

    CAS  PubMed  Google Scholar 

  4. Services. USDoAaUSDoHaH. Dietary Guidelines for Americans, 2020–2025. 2020; 9th Edition.

    Google Scholar 

  5. Sourianarayanane A, McCullough AJ. Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: an NHANES analysis. Clin Res Hepatol Gastroenterol. 2022;46(7):101997.

    Article  PubMed  Google Scholar 

  6. Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Japan Study Group Of Nafld Jsg-Nafld. FIB-4 first in the diagnostic algorithm of metabolic-dysfunction-associated fatty liver disease in the era of the global metabodemic. Life (Basel). 2021;11(2):143.

    CAS  PubMed  Google Scholar 

  7. Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36(1):13–20.

    Article  CAS  PubMed  Google Scholar 

  8. Caussy C, Chen J, Alquiraish MH, Cepin S, Nguyen P, Hernandez C, Yin M, Bettencourt R, Cachay ER, Jayakumar S, Fortney L, Hooker J, Sy E, Valasek MA, Rizo E, Richards L, Brenner DA, Sirlin CB, Ehman RL, Loomba R. Association between obesity and discordance in fibrosis stage determination by magnetic resonance vs transient elastography in patients with nonalcoholic liver disease. Clin Gastroenterol Hepatol. 2018;16(12):1974–1982.e7.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, Haflidadottir S, Bendtsen F. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389–97.

    Article  PubMed  Google Scholar 

  10. Sourianarayanane A, Challa SR. Non-alcoholic fatty liver: current management and future trends. Gut Gastroenterol. 2020;3:001–17.

    Google Scholar 

  11. Oseini AM, Sanyal AJ. Therapies in non-alcoholic steatohepatitis (NASH). Liver Int. 2017;37(Suppl 1):97–103. https://doi.org/10.1111/liv.13302.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sasaki A, Nitta H, Otsuka K, Umemura A, Baba S, Obuchi T, Wakabayashi G. Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments. Front Endocrinol (Lausanne). 2014;5:164.

    Article  PubMed  Google Scholar 

  13. Sourianarayanane A, Arikapudi S, McCullough AJ, Humar A. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation. Eur J Gastroenterol Hepatol. 2017;29(4):481–7.

    Article  PubMed  Google Scholar 

  14. Alvarez J, Mei X, Daily M, Shah M, Grigorian A, Berger J, Marti F, Gedaly R. Tipping the scales: liver transplant outcomes of the super obese. J Gastrointest Surg. 2016;20(9):1628–35.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA

    Achutan Sourianarayanane

Authors
  1. Achutan Sourianarayanane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Achutan Sourianarayanane .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA

    W. Harley Sobin

  2. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA

    Kia Saeian

  3. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA

    Patrick Sanvanson

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sourianarayanane, A. (2023). Treatment of MASLD. In: Sobin, W.H., Saeian, K., Sanvanson, P. (eds) Managing Complex Cases in Gastroenterology. Springer, Cham. https://doi.org/10.1007/978-3-031-48949-5_67

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-48949-5_67

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-48948-8

  • Online ISBN: 978-3-031-48949-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation